Stock Snapshot from
Celsion CorpAdd to My Watchlist
CLSN:USNASDAQ CMIndustry: Medical-Biomedical/Gene
- 1.31Last
- 0.10 8.26%Today's Change
- 1.21Previous Close
- 52 Week Low - High
Earnings
| EPS: Year Actual ttm | -0.580 |
| EPS: Year Est. 12/13 ttm | -- |
| EPS: Quarterly Actual 3/13 | -0.22 |
| EPS: Quarterly Est. 6/13 | -- |
| Price/Earnings ttm | -- |
| Relative Price/Earnings | -- |
| Earnings Growth Rate | 31.53 |
Company Description
| Celsion Corporation is a development company specializing in heat based treatments for cancer and other diseases. The Company's products include a heat activated liposomal form of doxorubicin for the treatment for liver and breast cancers. | |
| Revenue | $0 |
| Net Income | $-27 million |
| Total Assets | $25 million |
| Employees | 19 |
| Web Site | www.celsion.com |
Latest Headlines
No news available.
Watchlist
Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.